Clinical services network- clinical trial planning and execution
Ended Awarded Last action
- Contract number
- 75A50123F33005
- Awardee
-
Allucent Government Services (Us) LLC UEI C7DJDL6EZT94
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $370,059,439
Award facts
- Contract value 100% obligated
- $370,059,439.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Houston, TX 77060, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $26,849,802 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $343,209,637 |
About this award
The Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a delivery order valued at approximately $370 million to Allucent Government Services (US) LLC for clinical trial planning and execution in support of COVID next-generation vaccine development. The contract, awarded on August 22, 2023, with an ultimate completion date of April 11, 2025, operates under a Cost Plus Fixed Fee pricing structure with no set-aside designation. Work will be performed in Houston, Texas, where Allucent maintains its primary clinical research division. This delivery order is issued under ASPR's larger $550 million indefinite delivery vehicle for clinical trial planning and execution services, which serves as the contracting mechanism for multiple medical countermeasure programs supporting the federal government's public health preparedness initiatives.
Allucent Government Services, formerly known as Pharm-Olam LLC, is a specialized clinical research organization with extensive expertise in comprehensive clinical trial support across the entire product development lifecycle, particularly for infectious disease research and medical countermeasure development. The company brings significant experience managing federal clinical trial programs, including previous major task orders from ASPR and contracts with the National Institutes of Health and Department of Defense. Through this award, Allucent will leverage its established capabilities in clinical trial planning, execution, subject matter expert consultation, and regulatory support to advance the development of next-generation COVID vaccines as part of the federal government's ongoing pandemic preparedness and response efforts.
Quick answers
Who was awarded contract 75A50123F33005?
75A50123F33005 was awarded to Allucent Government Services (Us) LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on August 22, 2023.
How much is contract 75A50123F33005 worth?
The government has obligated $370,059,439 on 75A50123F33005.
Is contract 75A50123F33005 an order under another contract?
Yes. 75A50123F33005 is a delivery order under 75A50120D00016, an indefinite delivery contract.
Was contract 75A50123F33005 competed?
The extent of competition for 75A50123F33005 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award